ACI Formulations has been growing earnings at an average annual rate of 12.2%, while the Chemicals industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 6.4% per year. ACI Formulations's return on equity is 9.2%, and it has net margins of 6.3%.
Key information
12.17%
Earnings growth rate
12.17%
EPS growth rate
Chemicals Industry Growth
6.09%
Revenue growth rate
6.39%
Return on equity
9.18%
Net Margin
6.32%
Last Earnings Update
31 Mar 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How ACI Formulations makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
DSE:ACIFORMULA Revenue, expenses and earnings (BDT Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
5,577
353
1,074
0
31 Dec 25
5,518
359
1,043
0
30 Sep 25
5,296
347
996
0
30 Jun 25
5,174
371
958
0
31 Mar 25
5,007
432
887
0
31 Dec 24
4,942
440
875
0
30 Sep 24
4,718
359
857
0
30 Jun 24
4,935
325
869
0
31 Mar 24
4,975
283
856
0
31 Dec 23
5,049
249
844
0
30 Sep 23
5,096
239
843
0
30 Jun 23
4,960
235
833
0
31 Mar 23
4,834
249
817
0
31 Dec 22
4,683
258
816
0
30 Sep 22
4,521
263
799
0
30 Jun 22
4,247
243
774
0
31 Mar 22
4,298
279
775
0
31 Dec 21
4,242
277
762
0
30 Sep 21
4,038
247
743
0
30 Jun 21
3,865
213
714
0
31 Mar 21
3,841
192
646
0
31 Dec 20
3,682
152
698
0
30 Sep 20
3,520
105
702
0
30 Jun 20
3,424
93
727
0
31 Mar 20
3,385
76
794
0
31 Dec 19
3,539
83
786
0
30 Sep 19
3,854
118
783
0
30 Jun 19
4,052
129
810
0
31 Mar 19
4,087
130
727
0
31 Dec 18
4,364
115
720
0
30 Sep 18
4,438
130
761
0
30 Jun 18
4,153
117
700
0
31 Mar 18
4,015
139
771
0
31 Dec 17
3,712
193
697
0
30 Sep 17
3,632
238
653
0
30 Jun 17
3,663
263
638
0
31 Dec 16
3,160
228
589
0
30 Sep 16
3,056
202
529
0
30 Jun 16
3,093
211
515
0
30 Sep 15
2,771
190
424
0
Quality Earnings: ACIFORMULA has high quality earnings.
Growing Profit Margin: ACIFORMULA's current net profit margins (6.3%) are lower than last year (8.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ACIFORMULA's earnings have grown by 12.2% per year over the past 5 years.
Accelerating Growth: ACIFORMULA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ACIFORMULA had negative earnings growth (-18.4%) over the past year, making it difficult to compare to the Chemicals industry average (25.8%).
Return on Equity
High ROE: ACIFORMULA's Return on Equity (9.2%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/04 10:35
End of Day Share Price
2026/07/02 00:00
Earnings
2026/03/31
Annual Earnings
2025/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ACI Formulations PLC is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.